Clinical Trial

GEnomic Medicine in Kidney Transplantation Study

Study acronym: GEM-KiT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Investigator led, prospective, observational cohort study to detect genomic features which can predict outcomes following kidney transplantation. 1. Determine non-HLA genomic mismatches between donor-recipient pairs which impact kidney allograft survival following transplantation 2. Derive polygenic risk scores on pre-transplant blood and/or kidney biopsy samples which predict kidney allograft dysfunction 3. Derive polygenic risk scores on post-transplant blood and/or kidney biopsy samples which predict kidney allograft dysfunction
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-04-09; most recent amendment 2025-03-24.
Trial Details
NCT Number NCT06365411
Lead Sponsor Western Sydney Local Health District
Conditions Transplant Complication, Kidney Transplant Rejection
Enrollment 1,000 participants
Start Date 2025-06-03
Primary Completion 2030-01-01 (estimated)
Study Completion 2035-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-28